Indegene Limited (BOM:544172)

India · Delayed Price · Currency is INR

520.00

+2.65 (0.51%)

At close: May 27, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Enterprise Medical Solutions	9.30B	8.03B	6.01B	5.60B	4.32B
Enterprise Medical Solutions Growth	15.86%	33.57%	7.25%	29.81%	41.49%
Enterprise Commercial Solutions	24.61B	15.87B	15.29B	13.57B	10.16B
Enterprise Commercial Solutions Growth	55.03%	3.82%	12.66%	33.53%	79.99%
Others	1.20B	1.02B	1.41B	1.06B	754.78M
Others Growth	17.84%	-27.66%	32.64%	40.84%	147.25%
Brand Activation	-	3.48B	3.19B	2.83B	1.41B
Brand Activation Growth	-	8.96%	12.88%	99.91%	79.60%
Total	35.11B	28.39B	25.90B	23.06B	16.65B
Total Growth	23.64%	9.64%	12.29%	38.54%	70.06%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Europe	7.61B	7.95B	6.31B	4.64B
Europe Growth	-4.24%	25.96%	36.11%	-26.53%
India	194.00M	223.00M	356.00M	274.15M
India Growth	-13.00%	-37.36%	29.86%	-22.90%
North America (Excluding United States of America)	178.00M	8.00M	62.00M	6.32M
North America (Excluding United States of America) Growth	2125.00%	-87.10%	881.01%	-89.84%
Rest of The World	675.00M	626.00M	650.00M	471.61M
Rest of The World Growth	7.83%	-3.69%	37.83%	-27.57%
United States of America	19.74B	17.09B	15.68B	11.35B
United States of America Growth	15.47%	8.98%	38.17%	-27.62%
Total	28.39B	25.90B	23.06B	16.74B
Total Growth	9.64%	12.29%	37.77%	-27.42%

Source: S&P Global Market Intelligence.